Transdermal technology
Dr. R. Rox Anderson Joins BioChemics Scientific Advisory Board to Advise on Development of Dermatological Products
Dr. Roy Altman Joins BioChemics Scientific Advisory Board to Advise on Clinical Development of Targeted Osteoarthritis Therapy.
BioChemics & Beth Israel Deaconess Medical Center Announce Wound Healing Research Collaboration. April 8, 2008
Nanobac Pharmaceuticals, Inc. Announces Collaboration Agreement With BioChemics for Transdermal Therapeutic Formulation.
Tuesday March 25, 9:46 am ET
John Masiz founder of BioChemics is interviewed by Sky Radio from Valley Village, California. Radio interview includes topics about VALE and the future of BioChemics. Tuesday, March 4, 2008
